» Articles » PMID: 12130521

Plasmodium Falciparum Cysteine Protease Falcipain-2 Cleaves Erythrocyte Membrane Skeletal Proteins at Late Stages of Parasite Development

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Jul 20
PMID 12130521
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Plasmodium falciparum-derived cysteine protease falcipain-2 cleaves host erythrocyte hemoglobin at acidic pH and specific components of the membrane skeleton at neutral pH. Analysis of stage-specific expression of these 2 proteolytic activities of falcipain-2 shows that hemoglobin-hydrolyzing activity is maximum in early trophozoites and declines rapidly at late stages, whereas the membrane skeletal protein hydrolyzing activity is markedly increased at the late trophozoite and schizont stages. Among the erythrocyte membrane skeletal proteins, ankyrin and protein 4.1 are cleaved by native and recombinant falcipain-2 near their C-termini. To identify the precise peptide sequence at the hydrolysis site of protein 4.1, we used a recombinant construct of protein 4.1 as substrate followed by MALDI-MS analysis of the cleaved product. We show that falcipain-2-mediated cleavage of protein 4.1 occurs immediately after lysine 437, which lies within a region of the spectrin-actin-binding domain critical for erythrocyte membrane stability. A 16-mer peptide containing the cleavage site completely inhibited the enzyme activity and blocked falcipain-2-induced fragmentation of erythrocyte ghosts. Based on these results, we propose that falcipain-2 cleaves hemoglobin in the acidic food vacuole at the early trophozoite stage, whereas it cleaves specific components of the red cell skeleton at the late trophozoite and schizont stages. It is the proteolysis of skeletal proteins that causes membrane instability, which, in turn, facilitates parasite release in vivo.

Citing Articles

Malaria parasite cysteine and aspartic proteases as key drug targets for antimalarial therapy.

Adeoye A, Lobb K J Mol Model. 2025; 31(3):78.

PMID: 39920505 DOI: 10.1007/s00894-025-06303-0.


Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?.

Gonzalez J, Salas-Sarduy E, Alvarez L, Valiente P, Arni R, Pascutti P Curr Med Chem. 2023; 31(16):2234-2263.

PMID: 37711130 DOI: 10.2174/0929867331666230913165219.


Cysteine Proteases as Validated Targets for the Treatment of Neglected and Poverty-Related Parasitic Diseases.

Ettari R Int J Mol Sci. 2023; 24(12).

PMID: 37373243 PMC: 10299242. DOI: 10.3390/ijms241210097.


Roles of Virtual Screening and Molecular Dynamics Simulations in Discovering and Understanding Antimalarial Drugs.

Duay S, Yap R, Gaitano 3rd A, Santos J, Macalino S Int J Mol Sci. 2023; 24(11).

PMID: 37298256 PMC: 10253467. DOI: 10.3390/ijms24119289.


Comparative Degradome Analysis of the Bovine Piroplasmid Pathogens and .

Poklepovich T, Mesplet M, Gallenti R, Florin-Christensen M, Schnittger L Pathogens. 2023; 12(2).

PMID: 36839509 PMC: 9965338. DOI: 10.3390/pathogens12020237.